Establishing secure connection…Loading editor…Preparing document…

Healthcare Phase 1 Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE PHASE 1 AGREEMENT

Patient Information

Date of Birth:    Gender: Female   Male   Other

Insurance and Billing

Insurance Provider:

By signing this Agreement the patient (or responsible party) acknowledges financial responsibility for charges not covered by insurance, including co-payments, deductibles, non-covered services and services denied by the insurer. Patient agrees to provide current insurance information and to notify provider of changes.

Phase 1 Services — Description and Scope

Phase 1 consists of initial evaluation, diagnostic testing as required, formulation of a preliminary treatment plan, and limited therapeutic interventions intended to assess patient response. Specific procedures included in Phase 1 (select all that apply):

Clinical evaluation and history   Laboratory testing   Imaging studies   Initial therapeutic intervention

Risks, Benefits, and Alternatives

The patient acknowledges that Phase 1 interventions carry potential risks, which may include but are not limited to discomfort, allergic reaction, infection, unanticipated diagnostic findings, or lack of clinical benefit. The patient has been informed of the expected benefits and reasonable alternatives, including the option of no treatment or referral to another provider. Patient has had the opportunity to ask questions and understands that not all risks can be listed here.

Medical History

Consent and Authorization

By signing below the patient (or legal representative) consents to the provision of Phase 1 services described above by the treating provider. This consent includes authorization for necessary examinations, diagnostic tests, and treatments consistent with the accepted standard of care. Consent is voluntary and may be withdrawn in writing at any time, except to the extent that action has already been taken in reliance on this consent.

HIPAA and Privacy: The patient acknowledges receipt of the provider's privacy practices and authorizes the use and disclosure of protected health information as necessary for treatment, payment and healthcare operations. The patient authorizes release of information to other treating providers and insurers as required for continuity of care and claims processing. This authorization is valid until the expiration date below unless revoked earlier in writing.

Authorization to Communicate: I authorize the provider to communicate appointment reminders, test results, and clinical information via the contact methods provided above. If I do not authorize, I decline such communications.

I authorize communications via phone and email   I decline communications by phone/email

Additional Terms

Withdrawal and Termination: The patient may withdraw consent at any time by written notice. The provider reserves the right to terminate services if the patient fails to comply with recommended care, fails to attend scheduled appointments, or engages in behavior that jeopardizes staff or other patients.

Liability: To the fullest extent permitted by law, the provider's liability for services under this Agreement shall be limited to direct damages and shall exclude consequential or punitive damages. Nothing in this clause limits rights that cannot be waived by law.

Acknowledgement and Signature

I certify that the information I have provided is true and complete to the best of my knowledge. I have read and understand the terms of this Healthcare Phase 1 Agreement, including risks, benefits, financial responsibility, and privacy authorizations. I consent to the Phase 1 services as outlined unless otherwise indicated in writing below.

Printed Name:

Signature:

Relationship to Patient (if signing for patient):

Date:

Enter text✕

What the Healthcare Phase 1 Agreement Covers

A Healthcare Phase 1 Agreement is a formal contract that sets the scope, responsibilities, timeline, compensation, data handling, and regulatory obligations for an initial healthcare study phase or a pilot clinical program. It typically defines sponsor, investigational site, principal investigator duties, trial protocol references, patient consent handling, data ownership, reporting obligations, budget and payment terms, confidentiality, and compliance with applicable laws such as HIPAA and federal research oversight. Parties use it to align expectations before patient enrollment or pilot execution.

Why a Clear Phase 1 Agreement Matters

A well-drafted Healthcare Phase 1 Agreement reduces regulatory risk, clarifies budgets and data flows, protects patient privacy, and documents responsibilities for safety reporting and IRB interactions. Clear terms expedite study start and minimize disputes.

Why a Clear Phase 1 Agreement Matters

Who Typically Prepares and Signs This Agreement

The agreement is used by sponsors, clinical research organizations (CROs), investigational sites, and institutional compliance teams during early-stage studies.

  • Principal Investigator — Site lead responsible for protocol conduct, participant safety, and regulatory reporting.
  • Sponsor Representative — Manages funding, protocol obligations, and overall study oversight.
  • Institutional Official — Legal or contracts office that approves institutional terms and signatures.

Each organization usually routes the agreement through clinical, legal, and finance stakeholders to ensure IRB, budget, and compliance alignment before execution.

Primary Signers and Their Roles

Sponsor Representative

A contracting officer or clinical operations manager authorized to accept budget, indemnity, and publication terms on behalf of the sponsor; typically reviews clinical and regulatory clauses with legal counsel before signing.

Principal Investigator

A licensed investigator at the site who confirms the site can meet protocol requirements, ensure informed consent, and accept monitoring and reporting obligations; signature indicates readiness to begin enrollment.

Step-by-Step: Complete and Execute the Agreement

Follow these sequential steps to prepare, approve, and finalize a Healthcare Phase 1 Agreement with minimal rework.

  • 01
    Draft: Populate parties, protocol number, budget, and key dates.
  • 02
    Review: Legal, clinical, and finance teams verify terms and compliance.
  • 03
    IRB Clearance: Confirm IRB approval or pending submission before final execution.
  • 04
    Execute: Obtain authorized signatures and distribute fully signed copies.

How Electronic Completion Typically Flows

This overview describes the common routing when the agreement is completed and signed electronically.

  • Upload: Sender uploads the agreement PDF or DOCX to the eSignature platform.
  • Place Fields: Add signature, initial, date, and conditional fields for approvals.
  • Send to Signers: Invite signers by email or generate a secure signing link.
  • Capture Audit Trail: The system logs timestamps, IP addresses, and authentication events.

Recommended Online Workflow Settings

Configure these settings to maintain compliance while keeping signer friction low in electronic workflows.

Field Configuration
Signer Authentication Email verification with optional SMS two-factor authentication
Field Types Signature, initials, date, checkboxes, and text fields
Conditional Logic Show payment fields only after budget acceptance
Audit Trail Capture IP, timestamp, and action log for each signer

Technical and Integration Considerations

Choose a platform that supports secure signing, audit trails, and integrations to your clinical or finance systems.

  • Integrations: Salesforce, NetSuite, Microsoft 365
  • File Formats: PDF, DOCX, and fillable forms
  • Authentication: Email, SMS code, KBA optional

Proper integration reduces manual entry and ensures executed agreements flow into trial tracking, billing, and document retention systems.

Essential Clauses and Sections to Include

A professional Healthcare Phase 1 Agreement addresses responsibilities, data controls, payments, reporting, indemnity, and termination to reduce ambiguity and support compliance.

Scope of Work

Describe participant enrollment targets, study procedures, and deliverables in measurable terms, including key milestones and acceptance criteria to avoid disputes about performance.

Data Use

Specify how protected health information (PHI) will be collected, stored, transmitted and de-identified, and whether a separate Data Use Agreement (DUA) applies.

Budget & Payments

List per-subject compensation, milestone payments, invoicing procedures, expense categories, and timing to ensure predictable cash flow and auditability.

Compliance

Require adherence to IRB approvals, applicable statutes, and facility policies; include obligations for safety reporting and regulatory inspections.

Intellectual Property

Define ownership of study data, inventions, and any commercialization rights; clarify publication and confidentiality restrictions for both parties.

Termination & Liability

Spell out termination for convenience, breach remedies, limitation of liability, and insurance requirements to manage financial and operational risk.

Key Execution Milestones in Sequence

These numbered stages show the typical sequence from negotiation to study start for a Phase 1 agreement.

01

Initial Negotiation

Drafting and internal review of scope, budget, and regulatory language.

02

IRB Submission

Confirm IRB application and local approvals before final execution.

03

Contract Execution

Obtain authorized signatures from sponsor and site; distribute fully executed copies.

04

Study Initiation

Begin screening and enrollment once all prerequisites are satisfied.

Typical Time-Sensitive Deadlines to Track

Monitor these deadlines during pre-study and early execution to avoid compliance gaps or enrollment delays.

IRB Approval Needed:

Obtain prior to first subject enrollment; delays block study initiation.

Budget Reconciliation:

Finalize budget and payment milestones before invoicing begins.

Regulatory Reporting Timeline:

Report serious adverse events per protocol and regulatory requirements promptly.

Contract Amendment Deadlines:

Process amendments quickly to reflect protocol or budget changes.

Data Submission Windows:

Adhere to predefined timelines for data transfers and monitoring reviews.

eSignature Vendor Pricing Snapshot for Executing Agreements

Comparison of common eSignature vendor starting prices and basic capabilities relevant to Healthcare Phase 1 Agreement workflows.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by vendor Varies by vendor Varies by vendor Varies by vendor
Bulk Send Yes Yes Yes Yes Varies
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Practical Tips to Reduce Delays and Risk

Follow these best practices to minimize rework and protect patient data while executing a Phase 1 agreement.

Use Exact Legal Names
Confirm legal entity names and signatory authority before sending the agreement. Incorrect names delay execution and complicate tax and payment setups; require entity documents when in doubt.
Attach IRB and Protocol Docs
Include IRB approval letters, the full protocol, and informed consent templates as exhibits to the agreement so obligations are unambiguous and reviewers can cross-check requirements.
Use a BAA for PHI
If PHI is exchanged, attach a Business Associate Agreement or equivalent to satisfy HIPAA obligations and clearly allocate breach responsibilities and notification duties.
Document Payment Triggers
Define precisely when invoices are submitted, what supporting documentation is required, and payment terms to avoid disputes and missed reimbursements.

Common Preparation Mistakes to Avoid

  • Using informal or abbreviated party names that do not match legal registrations, causing delays in corporate or vendor approvals.
  • Leaving payment terms vague, such as 'payment upon completion', which leads to disputes over deliverable acceptance criteria.
  • Failing to secure IRB approval before execution, which can prevent enrollment and trigger regulatory noncompliance.
  • Overlooking required privacy addenda (BAA/DUA) when PHI is transferred, increasing breach and enforcement risk.

Potential Consequences of Errors or Noncompliance

HIPAA Enforcement: Potential civil penalties and corrective action
Contract Termination: Loss of funding or study suspension
Regulatory Referral: Reporting to oversight agencies or IRB sanctions
Financial Exposure: Liability for damages or indemnity obligations
Data Integrity Risk: Invalid or unusable study data due to poor procedures
Audit Findings: Negative findings that trigger remediation plans

Real-World Examples of Use

Two brief examples illustrate how organizations complete early-phase healthcare agreements and capture signatures while maintaining compliance.

Fertility Centers of Illinois

A clinical site streamlined patient consent and contract routing for a Phase 1 protocol using e-signatures.

  • Site adopted secure audit trails and BAA-backed workflows.
  • John Butler reported that the platform supported API integration and reliable audit trails, enabling faster execution while preserving HIPAA protections and clear recordkeeping for future audits.

Optica Ventures LLC

A sponsor used electronic agreements to centralize contract versions across multiple investigational sites.

  • Standardized templates reduced negotiation cycles.
  • The approach improved internal tracking and ensured each site received identical exhibits, simplifying budget reconciliation and monitoring of study milestones.

Frequently Asked Questions

Answers to common questions about signing, compliance, and post-execution handling for Healthcare Phase 1 Agreements.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users